» Articles » PMID: 22734645

LDLR-related Protein 10 (LRP10) Regulates Amyloid Precursor Protein (APP) Trafficking and Processing: Evidence for a Role in Alzheimer's Disease

Overview
Publisher Biomed Central
Date 2012 Jun 28
PMID 22734645
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Aβ peptide that accumulates in Alzheimer's disease (AD) is derived from amyloid precursor protein (APP) following proteolysis by β- and γ-secretases. Substantial evidence indicates that alterations in APP trafficking within the secretory and endocytic pathways directly impact the interaction of APP with these secretases and subsequent Aβ production. Various members of the low-density lipoprotein receptor (LDLR) family have been reported to play a role in APP trafficking and processing and are important risk factors in AD. We recently characterized a distinct member of the LDLR family called LDLR-related protein 10 (LRP10) that shuttles between the trans-Golgi Network (TGN), plasma membrane (PM), and endosomes. Here we investigated whether LRP10 participates in APP intracellular trafficking and Aβ production.

Results: In this report, we provide evidence that LRP10 is a functional APP receptor involved in APP trafficking and processing. LRP10 interacts directly with the ectodomain of APP and colocalizes with APP at the TGN. Increased expression of LRP10 in human neuroblastoma SH-SY5Y cells induces the accumulation of mature APP in the Golgi and reduces its presence at the cell surface and its processing into Aβ, while knockdown of LRP10 expression increases Aβ production. Mutations of key motifs responsible for the recycling of LRP10 to the TGN results in the aberrant redistribution of APP with LRP10 to early endosomes and a concomitant increase in APP β-cleavage into Aβ. Furthermore, expression of LRP10 is significantly lower in the post-mortem brain tissues of AD patients, supporting a possible role for LRP10 in AD.

Conclusions: The present study identified LRP10 as a novel APP sorting receptor that protects APP from amyloidogenic processing, suggesting that a decrease in LRP10 function may contribute to the pathogenesis of Alzheimer's disease.

Citing Articles

Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer's Disease and Other Proteinopathies.

Kotarba S, Kozlowska M, Scios M, Saramowicz K, Barczuk J, Granek Z Int J Mol Sci. 2024; 25(19).

PMID: 39409126 PMC: 11477428. DOI: 10.3390/ijms251910797.


Lrp10 suppresses IL7R limiting CD8 T cell homeostatic expansion and anti-tumor immunity.

Russell J, Chen L, Liu A, Wang J, Ghosh S, Zhong X EMBO Rep. 2024; 25(8):3601-3626.

PMID: 38956225 PMC: 11315911. DOI: 10.1038/s44319-024-00191-w.


LRP10 and α-synuclein transmission in Lewy body diseases.

Carreras Mascaro A, Grochowska M, Boumeester V, Dits N, Bilgi E, Breedveld G Cell Mol Life Sci. 2024; 81(1):75.

PMID: 38315424 PMC: 10844361. DOI: 10.1007/s00018-024-05135-0.


Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies.

Kong F, Wu T, Dai J, Zhai Z, Cai J, Zhu Z Front Pharmacol. 2023; 14:1205207.

PMID: 37771725 PMC: 10525376. DOI: 10.3389/fphar.2023.1205207.


Sex specific molecular networks and key drivers of Alzheimer's disease.

Guo L, Cao J, Hou J, Li Y, Huang M, Zhu L Mol Neurodegener. 2023; 18(1):39.

PMID: 37340466 PMC: 10280841. DOI: 10.1186/s13024-023-00624-5.


References
1.
Battle M, Maher V, McCormick J . ST7 is a novel low-density lipoprotein receptor-related protein (LRP) with a cytoplasmic tail that interacts with proteins related to signal transduction pathways. Biochemistry. 2003; 42(24):7270-82. DOI: 10.1021/bi034081y. View

2.
Scherzer C, Offe K, Gearing M, Rees H, Fang G, Heilman C . Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol. 2004; 61(8):1200-5. DOI: 10.1001/archneur.61.8.1200. View

3.
Icking A, Amaddii M, Ruonala M, Honing S, Tikkanen R . Polarized transport of Alzheimer amyloid precursor protein is mediated by adaptor protein complex AP1-1B. Traffic. 2007; 8(3):285-96. DOI: 10.1111/j.1600-0854.2006.00526.x. View

4.
Lane R, Raines S, Steele J, Ehrlich M, Lah J, Small S . Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J Neurosci. 2010; 30(39):13110-5. PMC: 3274732. DOI: 10.1523/JNEUROSCI.3872-10.2010. View

5.
De Strooper B, Annaert W . Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci. 2000; 113 ( Pt 11):1857-70. DOI: 10.1242/jcs.113.11.1857. View